Compare ETV & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Current Price
| Metric | ETV | OMCL |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Computer Manufacturing |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2005 | 2000 |
| Metric | ETV | OMCL |
|---|---|---|
| Price | $14.60 | $41.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $51.14 |
| AVG Volume (30 Days) | 213.1K | ★ 824.5K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $4.82 |
| P/E Ratio | ★ N/A | $470.06 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $10.64 | $22.66 |
| 52 Week High | $14.83 | $51.84 |
| Indicator | ETV | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 47.43 |
| Support Level | $14.04 | $29.19 |
| Resistance Level | $14.63 | $45.36 |
| Average True Range (ATR) | 0.16 | 1.71 |
| MACD | -0.00 | 0.50 |
| Stochastic Oscillator | 53.65 | 81.02 |
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.